Skip to main content
. Author manuscript; available in PMC: 2017 Nov 21.
Published in final edited form as: Mol Pharm. 2017 Oct 25;14(11):3709–3717. doi: 10.1021/acs.molpharmaceut.7b00469

Figure 7.

Figure 7

Changes in the anti-oxidant phase II gene levels, including Ho1, Nqo1, and Ugt1a1, after the oral administration of 100 mg/kg UA. The data are presented as the mean ± SD of the observed data in rat leukocytes. * The difference was statistically significant when p < 0.05 compared with the first time point.